In our study we minimized diagnostic variability by using only MDD subjects and observed a significant decrease in SAT1 expression in the brain, although SAT1 was increased in MDD-S (vs. MDD-NS), in blood, it did not reach significance. The gene discussed is SAT1; the disease is major depressive disorder.